Ajanta Pharma USA Revenue and Competitors
Estimated Revenue & Valuation
- Ajanta Pharma USA's estimated annual revenue is currently $18.3M per year.
- Ajanta Pharma USA's estimated revenue per employee is $231,532
Employee Data
- Ajanta Pharma USA has 79 Employees.
- Ajanta Pharma USA grew their employee count by 5% last year.
Ajanta Pharma USA's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President & CEO, North America | Reveal Email/Phone |
2 | SVP , Finance & HR | Reveal Email/Phone |
3 | SVP Commercial Operations | Reveal Email/Phone |
4 | Director, Contracts & Sales Operations | Reveal Email/Phone |
5 | Associate Director Marketing | Reveal Email/Phone |
6 | Sr. Director Supply Chain and Customer Service | Reveal Email/Phone |
7 | Senior Manager Finance | Reveal Email/Phone |
8 | Senior Manager, Finance & Accounting | Reveal Email/Phone |
9 | Senior Customer Service Representative | Reveal Email/Phone |
10 | Senior Staff Accountant | Reveal Email/Phone |
Ajanta Pharma USA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 27 | 29% | N/A | N/A |
#2 | $35.8M | 156 | 6% | N/A | N/A |
#3 | $5.4M | 27 | 23% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 72 | 50% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 45 | 15% | N/A | N/A |
#8 | $10.3M | 63 | 34% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Ajanta Pharma USA?
Ajanta Pharma USA Inc., based in Bridgewater, New Jersey, is a wholly owned subsidiary of Ajanta Pharma Ltd. Ajanta Pharma is committed to delivering quality generic drugs to patients, through collaboration with its industry partners. Ajanta Pharma is dedicated to superior service, supply chain reliability and flexibility to meet the unique needs to its customers. Since making the strategic decision to enter the US market, our Research and Development (R&D) team began developing a product portfolio of Abbreviated New Drug Application (ANDA) filings with a mix of Immediate-Release, Extended-Release, Delayed-Release, Orally Disintegrating Tablets and Powders.
keywords:N/A
N/A
Total Funding
79
Number of Employees
$18.3M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Bridgewater
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $21.3M | 79 | 18% | N/A |
#2 | $7.5M | 80 | 7% | N/A |
#3 | $10.2M | 85 | 2% | N/A |
#4 | $23.5M | 99 | 6% | N/A |
#5 | $22.1M | 101 | 7% | N/A |